Abstract:Background: Regeneration of tooth-supporting structures destroyed by periodontitis is a major goal of periodontal therapy. Periodontal tissue engineering utilizing growth and amelogenin-like factors (GAFs) applies advances in materials science and biology to regenerate alveolar bone, periodontal ligament, and cementum. Amelogenin-like factors (e.g., enamel matrix derivative [EMD]) and growth factors (e.g., platelet-derived growth factor [PDGF] and bone morphogenetic proteins [BMPs, also considered morphogens]) have demonstrated pleotrophic effects on the stimulation of several key events required for tissue regeneration including DNA synthesis, chemotaxis, differentiation, and matrix synthesis. Rationale: GAFs have been used for the treatment of periodontal disease as shown in preclinical and clinical studies. This systematic review evaluates the evidence to support the utilization of EMD and growth factors (GFs) for periodontal repair and regeneration associated with natural teeth. Focused question: In patients with periodontal osseous defects, what is the effect of GAFs compared with controls on clinical, radiographic, histologic, adverse, and patient-centered outcomes? Search protocol: Two investigators searched MEDLINE, pre-MEDLINE, and the Cochrane Oral Health Group trials register for clinical and preclinical studies published in English. Hand searches were performed on the International Journal of Periodontics and Restorative Dentistry, Journal of Clinical Periodontology, Journal of Dental Research, Journal of Periodontology, and Journal of Periodontal Research. Searches were performed for articles published through April 2002. In addition, investigators contacted manufacturers of GAF products for related unpublished data and studies in progress. Inclusion criteria: Randomized controlled clinical trials (RCTs), cohort studies, case-control studies, case reports, and preclinical (animal) randomized controlled investigations that included a cohort population diagnosed with periodontal disease and presenting data on intrabony/interproximal defects and/or furcation defects were screened. Exclusion criteria: In vitro studies or those that did not include quantifiable data with respect to clinical or bone measures were not included. Data collection and analysis: Meta-analyses were performed for studies that fulfilled the eligibility criteria for the following continuous variables: clinical attachment level (CAL), probing depth (PD), or bone level (radiographic, re-entry, or histologic). Heterogeneity was assessed to determine whether the differences among therapies were due to systematic confounding factors (as noted in study quality assessments). Main results: 1. Eight studies, representing 7 RCTs and 1 quasi-experimental study, representing a total population of 511 subjects were analyzed with respect to EMD. 2. The majority of the remaining papers had a low evidence rating. 3. Most reports were case studies or case series without controls. 4. There were insufficient data to conduct a meta-analysis on the effect of growth factors used in periodontal repair around teeth. Reviewers' conclusions: 1. There is evidence supporting the use of EMD for periodontal osseous defects to improve CAL and reduce PD, although long-term benefits have not been established. 2. EMD has demonstrated notable consistency among the studies investigated in terms of superiority to controls (in general compared to open flap debridement [OFD]). 3. EMD appears to be safe for single and multiple administrations in terms of lack of elicitation of antibody responses or other local/systemic inflammatory events. 4. Preclinical and initial clinical data for growth factors appear promising but are insufficient to draw definitive conclusions at this time.

Twenty Years of Enamel Matrix Derivative: the Past, the Present and the Future

Enamel Matrix Derivative: Preclinical Biologic Background

Application of Induced Pluripotent Stem (ips) Cells in Periodontal Tissue Regeneration

Enamel matrix proteins in the treatment of intra-bony defects. A prospective 24-month clinical trial

Periodontal regeneration with enamel matrix derivative in reconstructive periodontal therapy: a systematic review

The use of enamel matrix derivative alone versus in combination with bone grafts to treat patients with periodontal intrabony defects: a meta-analysis.

Presence of an enamel matrix protein derivative on human teeth following periodontal surgery

Adsorption of enamel matrix proteins to a bovine-derived bone grafting material and its regulation of cell adhesion, proliferation, and differentiation.

Effect of Enamel Matrix Derivative Liquid on Osteoblast and Periodontal Ligament Cell Proliferation and Differentiation

Effect of enamel matrix proteins on the periodontal connective tissue-material interface after wound healing

Enamel Matrix Proteins in the Regenerative Therapy of Deep Intrabony Defects

Effects of the Enamel Matrix Derivative on the Proliferation and Odontogenic Differentiation of Human Dental Pulp Cells.

Premature Osteoblast Clustering by Enamel Matrix Proteins Induces Osteoblast Differentiation Through Up-Regulation of Connexin 43 and N-Cadherin

Growth and amelogenin-like factors in periodontal wound healing. A systematic review

Components of enamel matrix derivative and cyto-differentiation induction effects: A literature review

Enamel Matrix Derivative Enhances the Odontoblastic Differentiation of Dental Pulp Stem Cells via Activating MAPK Signaling Pathways

Enamel Matrix Derivative (EMD) as an Adjunct to Non-surgical Periodontal Therapy: A Systematic Review

Enamel Matrix Proteins In The Regenerative Therapy Of Deep Intrabony Defects - A Multicentre Randomized Controlled Clinical Trial

Enamel Matrix Derivative Enhances the Proliferation and Osteogenic Differentiation of Human Periodontal Ligament Stem Cells on the Titanium Implant Surface

Gene Expression Profiles of Periodontal Ligament Cells Treated with Enamel Matrix Proteins in Vitro: Analysis Using Cdna Arrays

Treatment of periodontal defects with enamel matrix derivative: clinical evaluation at early healing stages